Molecular imaging predicts trastuzumab-deruxtecan (T-DXd) response in head and neck cancer xenograft models.
Saved in:
| Title: | Molecular imaging predicts trastuzumab-deruxtecan (T-DXd) response in head and neck cancer xenograft models. |
|---|---|
| Authors: | Naveed AB; Department of Otolaryngology, Vanderbilt University, Nashville, TN, USA., Mani L; Department of Otolaryngology, Vanderbilt University, Nashville, TN, USA., Mirza MB; Department of Surgery, Vanderbilt University, Nashville, TN, USA., McAdoo A; Department of Otolaryngology, Vanderbilt University, Nashville, TN, USA., Kondo T; Department of Otolaryngology, Vanderbilt University, Nashville, TN, USA., Tanaka H; Department of Otolaryngology, Vanderbilt University, Nashville, TN, USA., Meeks N; Department of Otolaryngology, Vanderbilt University, Nashville, TN, USA., Rosenthal E; Department of Otolaryngology, Vanderbilt University, Nashville, TN, USA., Hom M; Department of Otolaryngology, Vanderbilt University, Nashville, TN, USA. |
| Source: | Molecular oncology [Mol Oncol] 2025 Nov; Vol. 19 (11), pp. 3193-3204. Date of Electronic Publication: 2025 May 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1878-0261 |
|---|---|
| DOI: | 10.1002/1878-0261.70056 |
